Is it unethical to patent?

Is it unethical to patent?

The Covid-19 pandemic has prompted many companies to invest time and effort in developing technology that is aimed at helping care for, test, or treat people suffering from the disease. In normal times, these might be considered normal commercial activities and would be considered for patenting without a second thought. However, the fact that these developments are typically not being motivated by pure commercial gain but by a desire to do something for the public good causes many companies to question whether or not they should seeks patents, or any other form of intellectual property protection.

This concern is not unique to Covid-19. Similar concerns have been raised in the past by companies seeking to provide solutions to previous large-scale disasters such as the oil spill in the Gulf of Mexico following the explosion on the Deepwater Horizon platform, the fires and pollution from oil wells in the Gulf War and the Ebola virus outbreak in Africa. The companies are concerned both to do the right thing, and not to be seen as profiting from or exploiting the suffering of others.

It is useful to consider the difference between owning a right and using that right. Owning a patent right does not inherently prevent anyone from performing the invention. A patent right is an exclusive right; it is the right to stop someone from doing something, not an absolute barrier to anyone doing something. Patent laws in most countries provide statutory defences for certain types of actions that otherwise might be subject to the right.

The question of whether or not it is ethical to own a patent would not seem to be an issue. Ownership of such rights is a question of law and depends on the relationship between the company and the creator. If this is an ethical relationship, the ownership arising from the relationship should be ethical. While some commentators have questioned whether or not it is appropriate for private companies to own the IP results of technology developed with public funding, this is something that can be addressed in the conditions for that funding.

The main issue therefore appears to be the way in which a company uses its patent rights. A recent editorial in Nature[1] proposes that patent pooling is the best way to proceed when dealing with R&D to address the Covid-19 issue. A number of companies have come together the establish the Open Covid Pledge[2] in which the partners sign up to make their IP freely available for the purpose of ending the Covid-19 pandemic.

Both of these solutions illustrate that it is the behaviour of the patent owner that can be judged on ethical standards, not the fact of its ownership of patents.

By patenting, the developer of a technology has an opportunity to control how it is used. That control can be in the form of ensuring ethical behaviour, such as by preventing exploitative pricing, or ensuring non-discrimination in availability. The patent potentially allows a patent owner to punish unethical behaviour by anyone using the patented technology.

Put simply, a patent owner can determine the conditions that ensure patented technology becomes available to the public good, if it so desires. By patenting the invention, the owner can still use it in the normal commercial manner where an overriding public need is not present. Once Covid-19 is under control, it is possible that some of the inventions that have been created will have wider application and can form the basis of new businesses.

This is not a new concept. In 1959, Nils Bohlin at Volvo patented the three-point seat belt, an invention that has possibly saved more lives and prevent more injuries than any other in automotive technology. Volvo decided to release this invention to the world at large and lobbied for its widespread adoption[3].

As Volvo showed more than 50 years ago, it is possible to own a patent and use it ethically for the greater public good. Once a company has patented an invention, it is up to them how it is used in the market. If it does not patent, it has little ability to control how anyone else uses the technology, whether ethically or otherwise.

 

Martin Hyden, Patent & Trade Mark Attorney

 

[1] Coronavirus: everyone wins when patents are pooled https://www.nature.com/articles/d41586-020-01441-2

[2] https://opencovidpledge.org/

[3] https://www.forbes.com/sites/douglasbell/2019/08/13/60-years-of-seatbelts-volvos-great-gift-to-the-world/

Related News

Warning Notice – Scam Payment Letters
news

Warning Notice – Scam Payment Letters

Have you received a letter out-of-the-blue recently from an unfamiliar agency asking you to pay a fee to register your European Patent application? Look out for the scam letters that look official, but aren't. 

news

Coronavirus - UK IPO, EPO and EU IPO extensions and support

A simple overview of the current status from IPOs. Last updated 18th May 2020. 

EBA issues decision on the patentability of plants and animals
news

EBA issues decision on the patentability of plants and animals

On 14 May 2020, the Enlarged Board of Appeal (EBA) at the European Patent Office (EPO) issued its much-awaited decision G 3/19 on the patentability of plants and animals, otherwise known as “Pepper”.

news

Morgan Motors Case Study

Morgan Motor Company originally thought their most important asset was their range of hand built sports cars, after working Wynne-Jones, they realised their most important asset was their brand.

UPDATE - UK IPO support for those affected by Coronavirus
news

UPDATE - UK IPO support for those affected by Coronavirus

Exceptional extensions of time limits at the EUIPO to end on 18 May 2020.

The Executive Director of the EUIPO has announced that the all time limits on trade mark and design matters at the EUIPO expiring between 9 March 2020 and 17 May 2020 will expire on 18 May 2020. The EUIPO is not extending these time limits further.

If you have any questions then please get in touch with your usual Wynne-Jones contact.

BREAKING NEWS - German Federal Constitutional Court decides on UPC complaint
news

BREAKING NEWS - German Federal Constitutional Court decides on UPC complaint

The German Federal Constitutional Court has now issued its long-awaited decision (source) in case  2 BvR 739/17 which was a complaint against the German Ratification Law under which Germany was to ratify the UPC.

EPO announces extensions to deadlines due to COVID-19
news

EPO announces extensions to deadlines due to COVID-19

On Sunday 15 March 2020 the EPO published a notice advising it is invoking the provisions of Rule 134(2) EPC, and has extended all periods expiring on or after publication of the notice to 17 April 2020. This may be extended by the EPO upon publication of a further notice.

EUIPO extends all deadlines for Community Design and European Union Trade Marks
news

EUIPO extends all deadlines for Community Design and European Union Trade Marks

Last updated: 30 April 2020

The Executive Director of the EUIPO has today (29 April 2020) issued a decision regarding extensions for all time limits on trade mark and design matters at the EUIPO. In accordance with these decisions, all time limits expiring between 9 March 2020 and 17 May 2020 inclusive are extended until 18 May 2020.

 

aipex logo aipex logo aipex logo